A large number of individuals who took our initial online survey were ineligible because they did not have type 2 diabetes (n=249), were taking diabetes medications other than metformin (n=404), or had definite plans to begin taking insulin (n=35). This evidence concerns the gene INS and type 2 diabetes mellitus.